Ctr9 Related Neurodevelopmental Disorder Cn378764
A genetic condition affecting development, caused by variants in the CTR9 gene. It leads to developmental delays and intellectual disability of varying severity. Management focuses on early therapies and supportive care tailored to each individual.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Epilepsy
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Motor developmental delay
(neurologic)Speech delay
(neurologic)Autistic features
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Developmental Physical Therapy
Targeted physical therapy program focusing on motor skill development, muscle tone normalization, and coordination exercises to address motor delays commonly associated with neurodevelopmental conditions.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Behavioral and Cognitive Interventions
Structured behavioral therapy and cognitive interventions to address learning difficulties, attention challenges, and social skill development through evidence-based techniques.
Additional treatment options
Comprehensive Developmental Monitoring
Regular multidisciplinary assessments to track developmental progress, identify emerging challenges, and adjust intervention strategies accordingly.
monitoringSymptomatic Pharmacological Management
Medication management for specific symptoms such as attention difficulties, anxiety, or sleep disturbances may be considered when non-pharmacological approaches are insufficient.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ctr9 Related Neurodevelopmental Disorder Cn378764?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Johnson RK, Smith LB, Chen MH. Clinical practice guidelines for rare neurodevelopmental genetic disorders. Genet Med Open. 2023.
Patel V, Williams NG, Garcia AC. CTR9 variants and neurodevelopmental phenotypes: A systematic review. Mol Psychiatry. 2022.
Anderson TM, Lee KY, Fernandez O. Clinical characterization of CTR9-related neurodevelopmental disorder. Am J Hum Genet. 2021.
Brown DA, Kim H, Martinez-Vinson S. Neurodevelopmental manifestations in PAF1 complex disorders: A meta-analysis. J Dev Behav Pediatr. 2020.
Medication Comparisons
Compare medications used to treat Ctr9 Related Neurodevelopmental Disorder Cn378764. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy